Startups channel feed – Endpoints News

Startups channel feed

Friday IPO doubleheader from Maze and Metsera brings life to biotech debuts

5 months ago

8VC, a tech and life sciences VC firm behind Altos Labs, eyes $1B fund

5 months ago

Atalanta gets $97M boost to take two siRNAs into clinic for rare neuro disorders

5 months ago

Versant's fourth obesity biotech starts with $65M and a GIP antagonist

5 months ago

Obesity startup Found drives weight loss with low-cost generic drugs over GLP-1s, new study shows

5 months ago

Metsera outlines $250M IPO plans as obesity biotech competition rises

5 months ago

Maze looks to lead IPO queue with $113M Nasdaq debut

5 months ago

UK biotech launches with T cell therapy technology to treat solid tumors

5 months ago

With Sam Altman’s help, Retro Biosciences eyes $1B to extend lifespan by 10 years

5 months ago

Obesity biotech Aardvark files for IPO to advance oral, hunger-suppressing drug

5 months ago

Oncology biotech ArriVent does another China ADC deal, this time with Lepu Biopharma

5 months ago

Sionna and Odyssey end JPM week with IPO filings

5 months ago

Another US biotech emerges with drug candidate from China-based Keymed

5 months ago

Exclusive: Day after GSK buyout, IDRx chair takes new investing role at Curie.Bio

5 months ago

Normunity nabs $75M Series B to advance T cell engager and launch first trial

5 months ago

Lilly to acquire cancer biotech Scorpion, which shares a co-founder with Loxo

5 months ago

Chasing the next wave of obesity drugs, Metsera files for an IPO

6 months ago

Exclusive: Moderna's former top scientist has a new startup using AI to improve mRNA therapies

6 months ago

Another biotech scoops up asset from China-based Keymed and nabs $180M

6 months ago

Lilly ventures into pulmonary fibrosis with startup Mediar

6 months ago

With $120M, GSK-allied Ouro Medicines throws its hat into burgeoning TCE ring

6 months ago

Intellia to cut workforce by 27%, plans commercialization of first CRISPR therapy in 2027

6 months ago

Versant unveils Light Horse with $62M and a partnership with Novartis

6 months ago

Leyden Labs gets $70M to test if nasal sprays can help protect against viruses

6 months ago

First page Previous page 4 5 678 9 10 Next page Last page